Tempus AI Secures Up To $9.5 Million in US Agency Funding for Cardiology Agent

04:32 PM EDT, 09/09/2026 (MT Newswires) -- Tempus AI (TEM) was selected by the Advanced Research Projects Agency for Health to receive up to $9.5 million to develop an autonomous clinical AI agent for heart-failure care. The funding will support development and clinical validation of the system in a multicenter prospective study, the company said Wednesday in a statement. The agent will be designed to continuously monitor clinical and home-based data and manage symptoms, medications, virtual rehabilitation and scheduling. Tempus said the platform will connect with electronic health records for documentation and care coordination. The proposed agent builds on the company's existing AI products, including Olivia, Tempus Next and three FDA-cleared ECG-AI products.